Concepedia

Publication | Open Access

CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy

DOIFull Paper Access

111

Citations

28

References

2009

Year

Rudi Bao, Cheng-Jung Lai, Hui Qu, Da-Gong Wang, Ling Yin, Brian Zifcak, Ruzanna Atoyan, Jing Wang, Maria Samson, Jeffrey Forrester,
Clinical Cancer Research

Abstract

CUDC-305 is a promising drug candidate for the treatment of a variety of cancers, including brain malignancies.

References

YearCitations

Page 1